Loss Of Striatal Cannabinoid CB1 Receptor Function In Attention-deficit / hyperactivity Disorder Mice With Point-mutation Of The Dopamine Transporter

Attention Deficit Disorder (ADD) and Attention Deficit Hyperactivity Disorder (ADHD)

Key Findings

Results point to CB1 receptors as novel molecular players in ADHD, suggesting that therapeutic strategies aimed at interfering with the ECS might prove effective in this disorder.

Information and Links


Link: Loss Of Striatal Cannabinoid CB1 Receptor Function In Attention-deficit / hyperactivity Disorder Mice With Point-mutation Of The Dopamine Transporter

Year: 2011

DOI: 10.1111/j.1460-9568.2011.07876.x


Ratings

(How Ratings Work)

Attention Deficit Disorder (ADD) and Attention Deficit Hyperactivity Disorder (ADHD) — 2


Possible to probable range of efficacy of cannabis for treatment of Attention Deficit Disorder (ADD) and Attention Deficit Hyperactivity Disorder (ADHD) according to the results found in this study.

Drugs Used

CB1 cannabinoids and antagonists